Unrelated donor stem cell transplant (SCT) is a well established treatment option for patients with hematological malignancies. A major barrier to the success of this treatment is donor-recipient HLA mismatch (MM). HLA-A, B, C, and DRB1 MMs have been associated with early and severe acute GvHD and low survival rate. However, the extent and type of HLA MMs that modulate undesirable immune responses remains unclear.
The present study examines the effect of HLA MM at amino acid sequence level on day 100 survival (D100S). From 3,855 SCTs facilitated by the NMDP from 1988 to 2004, we selected 2,107 recipients with early- or intermediate-stage ALL, AML, CML, or MDS who were either matched with their donors at HLA-DRB1 but had a single HLA-class I MM at HLA-A (n=179), B (n=88), or C (n=333), or who were matched at HLA-A, B, C, and DRB1 (n=1,507). In this study population, of over 270 amino acid positions in each HLA class I loci, 59 amino acid positions had at least one amino acid substitution (AAS) in HLA-A, 46 positions in HLA-B, and 46 positions in HLA-C, for a total of 151 positions in HLA-A, B, and C.
A common approach to study the effect of AAS on SCT outcome is to perform separate analyses for individual substitutions (e.g.,
RF is a tree-based method for classification based on an ensemble of classification trees built by a doubly random process (
We carried out a RF analysis on 2,107 patient-donor pairs by specifying 151 AAS position variables and 4 patient characteristic variables (age, disease, disease status, and patient-donor gender match) as predictors of D100S. Using a RF of 500 trees and Gini criterion for measuring variable importance the following 16 variables, listed in order of importance, were identified by RF to be predictive of D100S: age, disease stage, HLA-C 116, HLA-C 156, HLA-A 152, HLA-C 99, HLA-C 219, HLA-A 9, HLA-C 9, disease type, gender match, HLA-B 116, HLA-A 156, HLA-A 62, HLA-A 114, and HLA-C 97. This list confirms some of the AAS positions previously identified in the literature.
In summary, RF is a useful screening tool that enables us to identify a small number of AAS position variables as important predictors of D100S. The positions and types of these AAS will be further investigated using more traditional multivariate regression techniques to elucidate the complex effect of specific HLA mismatches and their interactions.
Disclosures: No relevant conflicts of interest to declare.